Alector, Inc. Increase (Decrease) in Contract with Customer, Liability
Alector, Inc. (ALEC) reported Increase (Decrease) in Contract with Customer, Liability of -$4.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-06
- Alector, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$3.32M.
- Alector, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$1.05M.
- Alector, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$6.24M.
- Alector, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$3.26M.
- Alector, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$21.05M.
- Alector, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$100.56M.
- Alector, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$66.78M, a 200.60% decline from fiscal 2022.
- Alector, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $66.38M, a 77.34% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.37M 10-Q · filed 2026-08-06 | -$10.60M derived: sum of 3 quarters · filed 2026-08-06 | -$13.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.05M 10-Q · filed 2026-05-07 | -$7.28M derived: sum of 2 quarters · filed 2026-05-07 | -$10.54M derived: sum of 3 quarters · filed 2026-05-07 | -$18.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$9.50M derived: sum of 2 quarters · filed 2026-02-25 | -$17.37M derived: sum of 3 quarters · filed 2026-08-06 | -$21.05M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$11.13M derived: sum of 2 quarters · filed 2026-08-06 | -$14.81M 10-Q · filed 2025-11-06 | -$69.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$11.55M 10-Q · filed 2026-08-06 | -$65.79M derived: sum of 3 quarters · filed 2026-08-06 | -$81.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$3.67M 10-Q · filed 2026-05-07 | -$57.91M derived: sum of 2 quarters · filed 2026-05-07 | -$73.26M derived: sum of 3 quarters · filed 2026-05-07 | -$88.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$54.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$69.58M derived: sum of 2 quarters · filed 2026-02-25 | -$84.67M derived: sum of 3 quarters · filed 2026-02-25 | -$100.56M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$15.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$30.43M derived: sum of 2 quarters · filed 2025-11-06 | -$46.32M 10-Q · filed 2025-11-06 | -$61.51M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$15.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$30.98M 10-Q · filed 2025-08-07 | -$46.17M derived: sum of 3 quarters · filed 2025-08-07 | -$48.45M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$15.89M 10-Q · filed 2025-05-08 | -$31.08M derived: sum of 2 quarters · filed 2025-05-08 | -$33.37M derived: sum of 3 quarters · filed 2025-05-08 | -$83.93M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$15.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$17.47M derived: sum of 2 quarters · filed 2025-02-26 | -$68.03M derived: sum of 3 quarters · filed 2025-02-26 | -$66.78M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$52.84M derived: sum of 2 quarters · filed 2024-11-06 | -$51.59M 10-Q · filed 2024-11-06 | -$66.03M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$50.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$49.31M 10-Q · filed 2024-08-07 | -$63.75M derived: sum of 3 quarters · filed 2025-02-26 | -$78.60M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-08 | -$13.19M derived: sum of 2 quarters · filed 2025-02-26 | -$28.04M derived: sum of 3 quarters · filed 2025-02-26 | -$107.89M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$14.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$29.29M derived: sum of 2 quarters · filed 2025-02-26 | -$109.14M derived: sum of 3 quarters · filed 2025-02-26 | $66.38M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$14.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$94.70M derived: sum of 2 quarters · filed 2023-11-07 | $80.82M 10-Q · filed 2023-11-07 | $66.83M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$79.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $95.67M 10-Q · filed 2023-08-03 | $81.68M derived: sum of 3 quarters · filed 2024-02-27 | $399.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $175.53M 10-Q · filed 2023-05-04 | $161.53M derived: sum of 2 quarters · filed 2024-02-27 | $479.12M derived: sum of 3 quarters · filed 2024-02-27 | $472.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $303.59M derived: sum of 2 quarters · filed 2024-02-27 | $297.02M derived: sum of 3 quarters · filed 2024-02-27 | $292.92M 10-K · filed 2024-02-27 |
| 2021-09-30 | $317.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $311.02M derived: sum of 2 quarters · filed 2022-11-08 | $306.91M 10-Q · filed 2022-11-08 | $302.06M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$10.68M 10-Q · filed 2022-08-04 | -$15.53M derived: sum of 3 quarters · filed 2023-02-28 | -$21.43M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$4.11M 10-Q · filed 2022-05-05 | -$8.96M derived: sum of 2 quarters · filed 2023-02-28 | -$14.87M derived: sum of 3 quarters · filed 2023-02-28 | -$18.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$10.76M derived: sum of 2 quarters · filed 2023-02-28 | -$13.93M derived: sum of 3 quarters · filed 2023-02-28 | -$21.10M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$9.07M derived: sum of 2 quarters · filed 2021-11-04 | -$16.25M 10-Q · filed 2021-11-04 | -$22.25M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$10.34M 10-Q · filed 2021-08-03 | -$16.34M derived: sum of 3 quarters · filed 2022-02-24 | -$19.04M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$7.17M 10-Q · filed 2021-05-05 | -$13.17M derived: sum of 2 quarters · filed 2022-02-24 | -$15.87M derived: sum of 3 quarters · filed 2022-02-24 | -$22.79M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$8.70M derived: sum of 2 quarters · filed 2022-02-24 | -$15.61M derived: sum of 3 quarters · filed 2022-02-24 | -$21.22M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$9.61M derived: sum of 2 quarters · filed 2020-11-10 | -$15.22M 10-Q · filed 2020-11-10 | -$24.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$6.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$12.52M 10-Q · filed 2020-08-11 | -$21.67M derived: sum of 3 quarters · filed 2021-02-25 | -$28.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$5.61M 10-Q · filed 2020-05-13 | -$14.75M derived: sum of 2 quarters · filed 2021-02-25 | -$21.25M derived: sum of 3 quarters · filed 2021-02-25 | -$28.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$15.65M derived: sum of 2 quarters · filed 2021-02-25 | -$22.76M derived: sum of 3 quarters · filed 2021-02-25 | $172.49M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$13.61M derived: sum of 2 quarters · filed 2019-11-12 | $181.64M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$7.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $188.14M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $195.25M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $2.13M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |